‘The ultimate validation of a target is a successful clinical trial’: an interview with Maya Ghoussaini
In this interview, Dr. Maya Ghoussaini, Team Leader, Genetics Core Team at Open Targets, discusses the Open Targets Platform and the use of genetics to guide target identification and validation.
Please sign in or register for FREE
Sign in to RxNet
Register to RxNet
RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.